Wednesday 20 May 2015

Glenmark Pharma surges as RBI hikes FII limit

The stock has jumped 2 percent at the opening bell on the BSE. 

Glenmark Pharmaceuticals started the day with a gain of 2 percent at Rs. 918 after the Central Bank hiked the FII investment limit in the company.

According to media reports, the RBI has now allowed FII investment up to 49 percent in the company.

As per the shareholding pattern for the quarter ended March 2015, FIIs held 34.71 percent equity in the company.

The stock so far has jumped 3.4 percent to a high at Rs. 930 and is now up 2.3 percent at Rs. 920.

Around 17,000 shares are traded on the BSE counter, as against two-week daily average volume of 100,000 shares.

Meanwhile, the Sensex has jumped 200 points at 27,845. 

No comments:

Post a Comment